Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors.
about
Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E ProteinRecent advances in DENV receptorsCarbohydrate-related inhibitors of dengue virus entryNeuroblastoma Cell-Adapted Yellow Fever 17D Virus: Characterization of a Viral Variant Associated with Persistent Infection and Decreased Virus SpreadViral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate InteractionClosing the door on flaviviruses: Entry as a target for antiviral drug designStudies on the effect of calcium in interactions between heparin and heparin cofactor II using surface plasmon resonanceA brief review on dengue molecular virology, diagnosis, treatment and prevalence in PakistanPathogenesis and Inhibition of Flaviviruses from a Carbohydrate PerspectiveHeparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particlesAnthracene-based inhibitors of dengue virus NS2B-NS3 proteaseAn external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors.Heparin-binding domains in vascular biology.Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2.A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.Glycosaminoglycans in infectious disease.Bridging the past and the future of virology: surface plasmon resonance as a powerful tool to investigate virus/host interactions.Natural products as source of potential dengue antivirals.Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry.Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid.A Role for Human Skin Mast Cells in Dengue Virus Infection and Systemic Spread.Dengue virus entry as target for antiviral therapy.Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein.Molecular mimicry between virus and host and its implications for dengue disease pathogenesis.Further evidence that papillomavirus capsids exist in two distinct conformations.In vitro anti-thrombotic and anti-coagulant properties of blacklip abalone (Haliotis rubra) viscera hydrolysate.Label-Free Dengue Detection Utilizing PNA/DNA Hybridization Based on the Aggregation Process of Unmodified Gold Nanoparticles
P2860
Q26700124-AF43663D-E39E-4F7F-BD11-D9A3434712D0Q26863203-6795E742-51E8-4A7C-8987-406BF18F2434Q26864413-61170084-78BB-4300-AA5F-7893B2264D45Q27472880-53BA8085-BA59-4DA1-B0BD-5377D12448F8Q27477606-3BC44433-C445-4746-A654-544320DA3309Q27487953-2E212F6A-B3C6-46CA-B643-4D3A92044106Q28271545-04AB178E-63E2-4C8E-8FC3-66133037C2D0Q28715463-C34485DD-50F4-4C62-B562-76915DBC53EBQ29994529-F0F3A4D9-12D5-4616-908B-233CF7B13EE7Q33255972-85B2C381-E1F4-4762-BC00-EE6F09BCF0A8Q33852451-81D3432A-79E4-4F15-9C16-CD540C244523Q34093421-9CE5FB7B-35E6-45C0-BAE6-DF0BCDA3DDE5Q34516819-51C97A34-BE6F-4566-B106-1C7B4AB2930BQ34552933-0FC72CAC-6C62-4A74-8666-FFE9EC129074Q35192749-C21A5589-A15A-4C0E-90BF-6763415342AAQ35825233-315F9C7F-D54A-41EA-8B42-7FCAA101D061Q35855216-6C885C2A-5532-474E-AF16-CB7832FBFD69Q37812291-4018988C-2975-4378-89A6-C28F3CC953C5Q38095685-CEF81B45-F6D1-4E90-81BF-FD7ABD8E9907Q38141148-49CB0251-D2ED-4D35-85A6-C5415C5F55BFQ38221220-3EFDD2EC-7C42-4756-9C23-E52AA11C53B2Q38315447-E64ECA98-6125-420A-9EEF-1F90C800BF05Q38352468-EAAB36B3-AC66-488A-8593-0DA37EACC176Q39570438-E668566E-5598-4E85-AE12-B246D6114A73Q40082082-37EFAFF9-72F0-4841-8053-5813975C16B5Q40289267-3C0B8E6E-F263-4DC2-963B-1DCA2FAB497DQ40326276-FEFB9242-754E-48F0-8304-BA920CCDCEC0Q40327626-16E33348-9F36-44DA-99DE-80697869DCF1Q40344553-C997A442-3F6F-465B-8A00-C3486D5EB56CQ50656479-E60A5070-259E-405E-9D30-3F3E1078FD17Q59059296-939D0677-0AD9-4E5F-89CF-C2978C7939E6
P2860
Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Probing the interaction of den ...... minoglycan-derived inhibitors.
@en
type
label
Probing the interaction of den ...... minoglycan-derived inhibitors.
@en
prefLabel
Probing the interaction of den ...... minoglycan-derived inhibitors.
@en
P2093
P356
P1476
Probing the interaction of den ...... minoglycan-derived inhibitors.
@en
P2093
Hernáiz MJ
Sundaresan R
P304
P356
10.1021/JM000412I
P407
P577
2001-06-01T00:00:00Z